TGen-led study suggests a drug combination that might prove effective for 1 in 3 glioblastoma patients Posted Monday May 2, 2022 MLN4924 is associated with a ‘signature of vulnerability,’ providing a precision-medicine guide for planned nationwide clinical trials
TGen recognizes Lynda Carter Altman and the Salt River Pima-Maricopa Indian Community at its annual Founders Dinner Posted Thursday April 21, 2022
Could diet modification make chemotherapy drugs more effective for patients with pancreatic cancer? Posted Monday March 21, 2022 Laboratory experiments at Princeton University and TGen, testing a ketogenic diet, lead to nationwide clinical trial
TGen, HonorHealth and Irish biomedical team initiate promising ‘Nieto’ clinical trial against pancreatic cancer Posted Friday March 18, 2022 Named for a respected Arizona scientist, this trial uses a combination of drugs against advanced cancer in patients where other treatments have failed
‘Purple Pansies’ donates $1 million in support of TGen pre-clinical study Posted Wednesday February 23, 2022 Disrupting cancer cells’ ability to formulate proteins could open door to improved treatment of pancreatic cancer
TGen partners with Deepcell to advance detection, analysis and treatment of disease Posted Tuesday February 22, 2022 Technology platform provides state-of-the-art imaging and analysis of individual cells
Understudied lncRNAs could help enable early detection of potentially deadly liver disease Posted Tuesday February 8, 2022 TGen-Temple comprehensive review highlights recently discovered associations between long noncoding RNAs and specific diseases
TGen-UArizona medical school study points to possible new treatment options for breast cancer patients Posted Wednesday December 22, 2021 Cxcl10 protein can indicate both positive and negative directions of cancer trajectory
TGen helps develop analysis tool, leading to more-accurate evaluation of new brain tumor treatments and individual estimates of survival Posted Monday December 20, 2021 ‘Nomograms’ accounting for sex differences in the design of clinical trials should help deliver new precision treatments to glioblastoma patients
Applications open today for Helios Scholars at TGen and TGen Bioscience Leadership Academy Posted Monday December 13, 2021 Summer education programs focus on high school through college graduate students